(Hypertension. 1995;26:733.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Internal Medicine B (J.-A.H., G.B., G.W., P.N.) Centre Hospitalier Universitaire Vaudois, the Division of Hypertension (J.-F.A., J.N., B.W.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland, and the Hypertension Section (H.G.), Boston University Medical Center, Boston, Mass.
Correspondence to J.-A. Haefliger, PhD, Laboratory of Molecular Biology 19-521, Department of Internal Medicine B, Centre Hospitalier Universitaire Vaudois, CHUV1011 Lausanne, Switzerland.
| Abstract |
|---|
|
|
|---|
Key Words: renin RNA, messenger blood pressure renovascular hypertension receptors, angiotensin
| Introduction |
|---|
|
|
|---|
The renin release triggered by hypoperfusion of the stenosed kidney leads to an enhanced generation of Ang II.8 This octapeptide, beyond its contractile effect on the vasculature and its stimulatory action on aldosterone secretion from the adrenal glomerulosa, exerts a negative feedback control on renin expression and secretion9 10 and is probably the main factor involved in the inhibition of renin expression and secretion from juxtaglomerular cells located in the contralateral, unclipped kidney.11 12 13 However, other mechanisms possibly are involved in the attenuation of renin release from the intact kidney, including the elevation of blood pressure per se, the activation of the macula densa by a neuronal mechanism, and/or renorenal reflexes.14 15
The goal of the present study was to investigate the modulation of renal and AT1 gene expression in renovascular hypertension. Rats were subjected to unilateral renal artery clipping 4 weeks before death (long-term form of 2K1C hypertension). The renal mRNA levels of renin and AT1 were analyzed. The rat AT1 receptor has been cloned,16 localized in the kidneys,17 and recognized to mediate the known effects of Ang II.18 In the rat kidney, two subtypes of the AT1 receptor (AT1A and AT1B) have been described; they share 91% nucleic acid sequence identity in their coding region but differ in their 3' untranslated region.19 20 We used cDNA probes that specifically recognized AT1A or the AT1B.
| Methods |
|---|
|
|
|---|
RNA Isolation From Kidneys
The kidneys were homogenized in 9 mL of 4-mol/L
guanidine hydrothiocyanate buffer using a Kinametic Polytron blender
(Kriens) and layered onto a 4-mL 5.7-mol/L CsCl cushion. Total RNAs
were pelleted by ultracentrifugation at 33 000 rpm
for 20 hours in a 50-Ti rotor. PolyA+ RNA was obtained by
affinity chromatography on oligo[dT(+)] cellulose
(Calbiochem-Novabiochem AG) as previously described.23
Northern Blot Analysis
PolyA+ RNA (4 µg) was size-fractionated on 1%
agarose gels containing 8% formaldehyde (Fluka) and 1x MOPS buffer
(Fluka). Gels were transferred by capillary blotting (10x SSC) to Gene
Screen membranes (Du Pont). Membranes were UV cross-linked and
vacuum-baked for 2 hours at 80°C. mRNA levels were determined by
hybridization by random-primed (Boehringer Mannheim) with
[
-32P]dCTP (Amersham). Overnight hybridization was in
5x SSPE, 50% formamide, 5x Denhardts solution, 5% SDS, and 100
µg/mL purified salmon sperm DNA at 42°C. The blots were washed
three times at 42°C for 10 minutes in 2x SSC, 1% SDS and three
times for 20 minutes each in 0.1x SSC, 1% SDS. Exposure times of all
membranes to x-ray film (X-Omat AR, Kodak) were chosen to optimize the
signals in the linear range. To correct for variations in the amount of
polyA+ RNA loaded in each lane, Northern blots were
rehybridized with the ubiquitously expressed gene GAPDH.
DNA Probes
The probes used were the 0.7-kb EcoRI insert of
rat renin cDNA12 ; the 1.1-kb
(HindIII-EcoRI) fragment of GAPDH
cDNA,24 the 0.9-kb (Sac 1-BamHI)
fragment of the rat AT1A cDNA,16 and the
0.8-kb (HindIII) fragment of the rat AT1B
cDNA.23
Data Analysis
Densitometric analysis of mRNA signals on
autoradiograms was performed with a Molecular Dynamics
scanner (Sunnyvale). Densitometric values represent the
integration of the area and are corrected for the baseline background
reading. The ratio of the specific and the corresponding GAPDH signal
was determined and expressed relative to the minimum value to which an
arbitrary score of 1 was assigned.
Data are expressed as mean±SEM. Mean blood pressure, heart rate, body weight, kidney weight, and PRA were statistically analyzed using one-way superANOVA followed by Scheffés test. For the Northern blot analysis, relative mRNA levels were calculated and then statistically compared using superANOVA and Fishers least significant difference test. The correlation coefficients were calculated by linear regression. Statistical significance was defined at values of P<.05, P<.01, and P<.001.
| Results |
|---|
|
|
|---|
|
Renal Renin Gene Expression
Fig 1a illustrates typical Northern blots of
kidney PolyA+ RNA obtained from four 2K1C and four
sham-operated rats with a renin cDNA probe. An increased level of
renin mRNA in the clipped kidney of the 2K1C renal hypertensive rats
was observed, whereas the mRNA levels in the contralateral kidney were
significantly lower. No difference was seen between the two kidneys of
the control rats. The same blots were subsequently hybridized with a
GAPDH cDNA probe to allow a precise quantitative assessment of renin
expression normalized to the GAPDH gene expression.
|
Fig 1b shows the quantitative assessment of renin polyA+ RNA expression in both kidneys of the two groups of 10 rats. In 2K1C hypertensive rats, renin mRNA levels were markedly higher (250%) in the clipped left kidney (P<.001) compared with the contralateral kidney. It was also significantly increased (P<.001) in comparison with the kidneys obtained from sham-operated rats. Renin mRNA levels were decreased by 36% in the unclipped right kidney of the hypertensive rats compared with the right kidney of sham-operated animals (P<.01).
There was a close relationship in 2K1C hypertensive rats between renin mRNA expression measured in the clipped left kidney and PRA (r=.94, P<.01) (Fig 2). In the left kidney of sham-operated rats, the coefficient of correlation between the two parameters was r=.71 (P<.01).
|
AT1A and AT1B Receptor Subtypes Gene
Expression in Kidneys
Northern blots containing 10 µg of normotensive rat kidney
polyA+ RNA were hybridized with AT1A or
AT1B cDNA probes. As shown in Fig 3, the
AT1A transcript is more abundant than the AT1B
mRNA. Quantitative assessment of the expression of both receptor
subtypes shows an eightfold-higher increase in expression of the
AT1A versus the AT1B. The size of both
transcripts (2.3 kb) is similar. To quantify the expression of the two
AT1 subtype transcripts in the kidney of the 2K1C
hypertensive rats, we used the specific AT1A or
AT1B probe.
|
Fig 4a shows the results obtained after hybridization with the AT1A probe of kidney polyA+ RNA from four representative 2K1C hypertensive rats and four sham-operated controls. Blots were stripped and rehybridized with the GAPDH probe as internal control.
|
A quantitative analysis of the AT1A receptor subtype mRNA in the left and the right kidneys of the two groups of 10 animals is given in Fig 4b. The AT1A receptor mRNA expression was 60% lower in both kidneys of the hypertensive animals compared with the corresponding controls (P<.05).
These Northern blots were subsequently stripped and hybridized with the AT1B probe. Quantitative assessment of the AT1B expression demonstrates no difference between the kidneys of the 2K1C or the sham-operated animals (Fig 5).
|
Fig 6 shows the relationship between AT1A mRNA expression measured in the left kidney of the 2K1C and sham-operated rats (on the ordinate) and PRA (on the abscissa). There was a significant inverse correlation between the two parameters in hypertensive rats (r=-.71, P<.01) but not in normotensive controls. In the right kidney of 2K1C rats, a significant inverse correlation was also observed (r=-.86, P<.01), whereas no relationship was noted in the right kidney of normotensive rats (not shown).
|
Considering the AT1B mRNA expression and PRA, no significant correlation was seen in hypertensive (r=.39, P=NS) as well as in normotensive (r=.20, P=NS) rats.
| Discussion |
|---|
|
|
|---|
Renin secretion is known to be suppressed in the kidney contralateral to the stenosed renal artery. This has been extensively studied in humans with renovascular hypertension. Blood sampling in the renal veins is commonly used to demonstrate lateralization of renin release, which points to a significant involvement of the renal artery stenosis in the pathogenesis of human hypertension.25 Renin release from renal slices is lower in the unclipped than in the clipped kidney of rats with 2K1C hypertension.11 It is now established that the reduced renin release from the intact kidney is associated with decreased renin mRNA levels.12 13 15 26 The suppression of renin gene expression manifest in the unclipped kidney of 2K1C renal hypertensive rats is thought to be primarily due to high circulating Ang II levels. This is in agreement with the finding that Ang II downregulates renal renin mRNA expression.10 13
The novel finding of this study is the specific modulation of the renal AT1A but not AT1B receptor subtype gene expression. The AT1A receptor has been cloned in rats and humans.16 20 It belongs to the class of G proteincoupled seven-transmembrane receptors and mediates the Ang II effects on the cardiovascular system.18 In the rat, two different subtypes of the AT1 receptor exist, the AT1A and the AT1B receptors.16 20 They are differentially regulated in various organs, including the liver, the adrenal gland, the pituitary gland, and the brain.19 In the rat kidney, the AT1A receptor is the predominantly expressed subtype. Whether the AT1A and AT1B receptors mediate similar signal transductions in the kidney remains to be elucidated.
Ang II, like other hormones, might be expected to modulate the number of AT1 receptors. In fact, binding studies performed in 2K1C renal hypertensive rats 7 days after clipping have revealed a reduction of glomerular receptors in the stenosed compared with the intact kidney.27 The present findings provide direct information on the renal gene expression of the AT1 receptor in rats with a sustained renin-dependent form of hypertension. The probes used made it possible to recognize the AT1A and AT1B subtypes. This is noteworthy because distinct responses were seen in the kidneys of our 2K1C rats in terms of mRNA expression of these two subtypes. The AT1B receptor mRNA was present at lower levels than was the AT1A receptor mRNA. Moreover, its expression was similar in hypertensive and normotensive rats, with no difference existing between clipped and unclipped kidneys. In contrast, a downregulation of the AT1A receptor was evidenced in 2K1C renal hypertensive rats. This downregulation was of similar magnitude in both kidneys, which is compatible with the involvement of a circulating factor. A causal relationship between circulating Ang II and the change in AT1A mRNA expression is suggested by the significant inverse correlation found between PRA and the AT1A receptor gene expression.
In conclusion, these data confirm that renal renin gene expression is increased in the stenosed kidney and suppressed in the contralateral, nonoperated kidney of rats with established, 2K1C renal hypertension. They also show a different renal gene expression of the two subtypes of the AT1 receptor, the AT1A receptor being bilaterally downregulated and the AT1B being unchanged. The downregulation of the AT1A receptor expression was inversely correlated with PRA, suggesting a role for Ang II in this gene regulatory response.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
Received March 24, 1995; first decision May 15, 1995; accepted August 10, 1995.
| References |
|---|
|
|
|---|
2. Leenen FHH, De Jong W, De Wied D. Renal venous and peripheral plasma renin activity in renal hypertension in the rat. Am J Physiol.. 1973;225:1513-1518.
3. Bengis RG, Coleman TG. Antihypertensive effect of prolonged blockade of angiotensin formation in benign and malignant, one and two kidney Goldblatt hypertensive rats. Clin Sci.. 1979;57:53-62. [Medline] [Order article via Infotrieve]
4. De Nicola L, Keiser JA, Blantz RC, Gabbai FB. Angiotensin II and renal functional reserve in rats with Goldblatt hypertension. Hypertension. 1992;19(pt 2):790-794.
5.
Brunner HR, Kirshmann JD, Sealey JE, Laragh JH.
Hypertension of renal origin: evidence for two different
mechanisms. Science.. 1971;174:1344-1346.
6. Morton JJ, Wallace ECH. The importance of the renin-angiotensin system in the development and maintenance of hypertension in the two-kidney, one-clip hypertensive rat. Clin Sci.. 1983;64:359-370. [Medline] [Order article via Infotrieve]
7. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans BMWM. In vivo pharmacology of DuP 753. Am J Hypertens.. 1991;4:288s-298s.
8. Oparil S, Haber E. The renin-angiotensin system. N Engl J Med.. 1974;291:389-401.
9.
Johns DW, Peach MJ, Gomez RA, Inagami T, Cavey RM.
Angiotensin II regulates renin gene
expression. Am J Physiol.. 1990;259:F882-F887.
10. Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol.. 1992;263:E863-E869.
11. De Jong W. Release of renin by rat kidney slices: relationship by plasma renin after desoxycorticosterone and renal hypertension. Proc Soc Exp Biol Med.. 1969;130:85-88. [Medline] [Order article via Infotrieve]
12.
Makrides SC, Mulinari R, Zannis UI, Gavras H.
Regulation of renin gene expression in hypertensive
rats. Hypertension.. 1988;12:405-410.
13. Von Thun AM, El-Dahr SS, Vari RC, Navar LG. Modulation of renin-angiotensin and kallikrein gene expression in experimental hypertension. Hypertension. 1994;23(suppl I):I-131-I-136.
14. Kopp UC, Smith IA, Di Bona GF. Renorenal reflexes: neural components of ipsilateral and contralateral renal responses. Am J Physiol.. 1985;249:F507-F517.
15. Holmer S, Eckardt KU, Aedtner O, Lettir M, Schricker K, Hamann R, Götz K, Riegger G, Moll W, Kurtz A. Which factor mediates reno-renal control of renin gene expression? J Hypertens.. 1993;11:1011-1019. [Medline] [Order article via Infotrieve]
16. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type 1 angiotensin II receptor. Nature.. 1991;351:233-236. [Medline] [Order article via Infotrieve]
17. Terada Y, Tomita K, Nonoguchi H, Marumo F. PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int.. 1993;43:1251-1259. [Medline] [Order article via Infotrieve]
18. Timmermans PBWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev.. 1993;45:205-251. [Medline] [Order article via Infotrieve]
19.
Gasc JM, Shanmugam S, Sibony M, Corvol P.
Tissue-specific expression of type 1 angiotensin
II receptor subtypes: an in situ hybridization study.
Hypertension.. 1994;24:531-537.
20.
Sandberg K, Hong J, Clark AJL, Shapira H, Catt KJ.
Cloning and expression of a novel angiotensin II
subtype. J Biol Chem.. 1992;267:9455-9458.
21. Flückiger JP, Gremaud G, Waeber B, Kulik A, Ichino A, Nussberger J, Brunner HR. Measurement of sympathetic nerve activity in the unanesthetized rat. J Appl Physiol.. 1989;167:250-255.
22. Nussberger J, Fasanella dAmore T, Porchet M, Waeber B, Brunner DB, Brunner HR, Kler L, Brown AN, Francis RJ. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers. J Cardiovasc Pharmacol.. 1987;9:39-44. [Medline] [Order article via Infotrieve]
23. Medcalf RL, Richards RI, Crawford RJ, Hamilton JA. Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids. EMBO J.. 1986;5:2217-2222. [Medline] [Order article via Infotrieve]
24.
Fort P, Marty L, Piechaczyck M, el Sabrouty S, Dani C,
Jeanteur P, Blanchard JM. Various rat adult tissues express only
one major mRNA species from
glyceraldehyde-3-phosphate-dehydrogenase multigenic
family. Nucleic Acids Res.. 1985;13:1431-1442.
25. Mann SJ, Pickering TG. Detection of renovascular hypertension: state of the art. Ann Intern Med.. 1992;117:845-853.
26.
Schricker K, Holmer S, Hamann M, Riegger G, Kurtz A.
Interrelation between renin mRNA levels, renin secretion, and
blood pressure in two-kidney, one-clip rats.
Hypertension.. 1994;24:157-162.
27.
Wilkes BM, Pion I, Sollott S, Michaels S, Kiesel G.
Intrarenal renin-angiotensin system modulates
glomerular angiotensin receptors in the
rat. Am J Physiol.. 1988;254:F345-F350.
This article has been cited by other articles:
![]() |
J. Xia, E. Seckin, Y. Xiang, M. Vranesic, W. B. Mathews, K. Hong, D. A. Bluemke, L. O. Lerman, and Z. Szabo Positron-Emission Tomography Imaging of the Angiotensin II Subtype 1 Receptor in Swine Renal Artery Stenosis Hypertension, February 1, 2008; 51(2): 466 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Helle, O. B. Vagnes, and B. M. Iversen Angiotensin II-induced calcium signaling in the afferent arteriole from rats with two-kidney, one-clip hypertension Am J Physiol Renal Physiol, July 1, 2006; 291(1): F140 - F147. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Bivol, O. B. Vagnes, and B. M. Iversen The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension Am J Physiol Renal Physiol, August 1, 2005; 289(2): F393 - F400. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-L. Tian, Y. M. Pinto, O. Costerousse, W. M. Franz, A. Lippoldt, S. Hoffmann, T. Unger, and M. Paul Over-expression of angiotensin converting enzyme-1 augments cardiac hypertrophy in transgenic rats Hum. Mol. Genet., July 15, 2004; 13(14): 1441 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-A. Haefliger, P. Nicod, and P. Meda Contribution of connexins to the function of the vascular wall Cardiovasc Res, May 1, 2004; 62(2): 345 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Jin, N. Fukuda, J.-Z. Su, Y.-M. Lai, R. Suzuki, Y. Tahira, H. Takagi, Y. Ikeda, K. Kanmatsuse, and H. Miyazaki Angiotensin II Type 2 Receptor Gene Transfer Downregulates Angiotensin II Type 1a Receptor in Vascular Smooth Muscle Cells Hypertension, May 1, 2002; 39(5): 1021 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Harrison-Bernard, S. S. El-Dahr, D. F. O'Leary, and L. G. Navar Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II–Induced Hypertension Hypertension, January 1, 1999; 33(1): 340 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-A. Haefliger, E. Castillo, G. Waeber, G. E. Bergonzelli, J.-F. Aubert, E. Sutter, P. Nicod, B. Waeber, and P. Meda Hypertension Increases Connexin43 in a Tissue-Specific Manner Circulation, February 18, 1997; 95(4): 1007 - 1014. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |